$ALNY
ALNYLAM PHARMACEUTICALS, INC.

2019 Q2 Form 10-Q Financial Statement

#000156459019029367 Filed on August 06, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2
Revenue $44.71M $29.91M
YoY Change 49.51% 87.72%
Cost Of Revenue $4.326M
YoY Change
Gross Profit $40.39M
YoY Change
Gross Profit Margin 90.33%
Selling, General & Admin $112.8M $84.68M
YoY Change 33.17% 84.89%
% of Gross Profit 279.21%
Research & Development $163.9M $137.6M
YoY Change 19.12% 51.86%
% of Gross Profit 405.79%
Depreciation & Amortization $9.800M $2.200M
YoY Change 345.45% -29.03%
% of Gross Profit 24.26%
Operating Expenses $276.7M $222.3M
YoY Change 24.47% 62.94%
Operating Profit -$236.3M -$192.4M
YoY Change 22.83%
Interest Expense $0.00 $6.100M
YoY Change -100.0% 134.62%
% of Operating Profit
Other Income/Expense, Net $17.75M $28.87M
YoY Change -38.52% -5874.6%
Pretax Income -$218.5M -$163.5M
YoY Change 33.67% 38.05%
Income Tax $960.0K $79.00K
% Of Pretax Income
Net Earnings -$219.5M -$163.6M
YoY Change 34.19% 38.12%
Net Earnings / Revenue -490.86% -546.9%
Basic Earnings Per Share
Diluted Earnings Per Share -$2.021M -$1.628M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.927B $1.448B
YoY Change 33.1% 56.8%
Cash & Equivalents $1.136B $361.5M
Short-Term Investments $790.5M $1.086B
Other Short-Term Assets $65.60M $51.90M
YoY Change 26.4% 135.91%
Inventory $40.59M
Prepaid Expenses
Receivables $30.74M $3.000M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.064B $1.503B
YoY Change 37.35% 56.41%
LONG-TERM ASSETS
Property, Plant & Equipment $371.8M $227.8M
YoY Change 63.17% 54.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets $9.687M $14.17M
YoY Change -31.62% -90.65%
Total Long-Term Assets $652.6M $286.8M
YoY Change 127.57% -39.44%
TOTAL ASSETS
Total Short-Term Assets $2.064B $1.503B
Total Long-Term Assets $652.6M $286.8M
Total Assets $2.716B $1.789B
YoY Change 51.81% 24.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $71.22M $11.99M
YoY Change 494.05% -48.33%
Accrued Expenses $138.8M $89.87M
YoY Change 54.45% 105.18%
Deferred Revenue $89.24M $9.161M
YoY Change 874.15%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $328.6M $113.7M
YoY Change 189.11% 4.56%
LONG-TERM LIABILITIES
Long-Term Debt $30.00M $30.00M
YoY Change 0.0% -80.0%
Other Long-Term Liabilities $9.514M $4.186M
YoY Change 127.28% -92.04%
Total Long-Term Liabilities $9.514M $4.186M
YoY Change 127.28% -97.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $328.6M $113.7M
Total Long-Term Liabilities $9.514M $4.186M
Total Liabilities $959.2M $168.6M
YoY Change 468.97% -45.84%
SHAREHOLDERS EQUITY
Retained Earnings -$3.242B -$2.384B
YoY Change 35.99%
Common Stock $5.035B $4.039B
YoY Change 24.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.757B $1.621B
YoY Change
Total Liabilities & Shareholders Equity $2.716B $1.789B
YoY Change 51.81% 24.76%

Cashflow Statement

Concept 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income -$219.5M -$163.6M
YoY Change 34.19% 38.12%
Depreciation, Depletion And Amortization $9.800M $2.200M
YoY Change 345.45% -29.03%
Cash From Operating Activities $288.7M -$102.7M
YoY Change -381.11% 26.63%
INVESTING ACTIVITIES
Capital Expenditures -$21.30M -$22.70M
YoY Change -6.17% 5.09%
Acquisitions
YoY Change
Other Investing Activities -$268.2M $85.40M
YoY Change -414.05% -285.65%
Cash From Investing Activities -$289.5M $62.60M
YoY Change -562.46% -192.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 412.6M 5.600M
YoY Change 7267.86% -98.55%
NET CHANGE
Cash From Operating Activities 288.7M -102.7M
Cash From Investing Activities -289.5M 62.60M
Cash From Financing Activities 412.6M 5.600M
Net Change In Cash 411.8M -34.50M
YoY Change -1293.62% -114.53%
FREE CASH FLOW
Cash From Operating Activities $288.7M -$102.7M
Capital Expenditures -$21.30M -$22.70M
Free Cash Flow $310.0M -$80.00M
YoY Change -487.5% 34.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Shell Company
EntityShellCompany
false
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
770602661
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
770602661
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents Current Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList
us-gaap:PrepaidExpenseAndOtherAssetsCurrent
CY2018Q2 us-gaap Restricted Cash And Cash Equivalents Current Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList
us-gaap:PrepaidExpenseAndOtherAssetsCurrent
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsNoncurrentAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2018Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsNoncurrentAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity File Number
EntityFileNumber
001-36407
dei Entity Address Address Line1
EntityAddressAddressLine1
300 Third Street,
dei Entity Address City Or Town
EntityAddressCityOrTown
Cambridge
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02142
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
551-8200
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1136289000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
420146000
CY2019Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
790542000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
662803000
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
74919000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
2063773000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
1200696000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
30739000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18760000
CY2019Q2 us-gaap Inventory Net
InventoryNet
40587000
CY2018Q4 us-gaap Inventory Net
InventoryNet
24068000
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
65616000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
29347000
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
3571000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
371769000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
320658000
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
89242000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3496000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
328604000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
179494000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-33213000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3242368000
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
226357000
CY2019Q2 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
44825000
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
277211000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
57920000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
101177000
CY2019Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
313887000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101177000
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
1110000
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
458000
CY2019Q2 us-gaap Secured Long Term Debt
SecuredLongTermDebt
30000000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
1011000
CY2018Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
44825000
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9687000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8623000
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5034284000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4175139000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-35831000
CY2019Q2 us-gaap Assets
Assets
2716411000
CY2018Q4 us-gaap Assets
Assets
1574802000
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
71215000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
59708000
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
138800000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
112719000
CY2018Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
30000000
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9514000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4965000
CY2019Q2 us-gaap Liabilities
Liabilities
959216000
CY2018Q4 us-gaap Liabilities
Liabilities
272837000
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
111114000
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
111114000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2840972000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1757195000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1301965000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2716411000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1574802000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44714000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29907000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78008000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51806000
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4326000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7673000
us-gaap Net Income Loss
NetIncomeLoss
-304774000
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.02
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.63
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.75
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.04
us-gaap Operating Income Loss
OperatingIncomeLoss
-425059000
us-gaap Operating Income Loss
OperatingIncomeLoss
-339759000
CY2019Q2 us-gaap Investment Income Net
InvestmentIncomeNet
8781000
CY2018Q2 us-gaap Investment Income Net
InvestmentIncomeNet
6101000
us-gaap Investment Income Net
InvestmentIncomeNet
16306000
us-gaap Investment Income Net
InvestmentIncomeNet
11895000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-453000
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
108576000
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
100519000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
106997000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
163890000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
137582000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
293017000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
234439000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
112769000
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
84679000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
202377000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
157126000
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
280985000
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
222261000
us-gaap Costs And Expenses
CostsAndExpenses
503067000
us-gaap Costs And Expenses
CostsAndExpenses
391565000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-236271000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-192354000
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2208000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-410000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2543000
CY2019Q2 alny Change In Fair Value Of Liability Obligation
ChangeInFairValueOfLiabilityObligation
9422000
alny Change In Fair Value Of Liability Obligation
ChangeInFairValueOfLiabilityObligation
9422000
CY2018Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
20564000
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
20564000
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
17750000
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
28873000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
25318000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
35002000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-218521000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-163481000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-399741000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-304757000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
960000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
79000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1655000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-219481000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-163560000
us-gaap Net Income Loss
NetIncomeLoss
-401396000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
100251000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-219481000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-163560000
us-gaap Net Income Loss
NetIncomeLoss
-401396000
us-gaap Net Income Loss
NetIncomeLoss
-304774000
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1046000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
822000
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
462000
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1046000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
1754805000
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2561000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
626000
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
842000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
842000
CY2019Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
4282000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
4282000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-222459000
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-162514000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-404014000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-304148000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
1546986000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6182000
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
4022000
CY2019Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
1089000
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
390577000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30798000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2978000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-219481000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1757195000
CY2018Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
3124000
CY2018Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
829000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21997000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-163560000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
1620802000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1301965000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
17591000
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
3964000
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
1873000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
63339000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2618000
us-gaap Net Income Loss
NetIncomeLoss
-401396000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1757195000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
1766431000
us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
68210000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
44451000
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
3001000
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
1397000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
41460000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
626000
us-gaap Net Income Loss
NetIncomeLoss
-304774000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
1620802000
us-gaap Profit Loss
ProfitLoss
-401396000
us-gaap Profit Loss
ProfitLoss
-304774000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
21955000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
5417000
us-gaap Share Based Compensation
ShareBasedCompensation
62635000
us-gaap Share Based Compensation
ShareBasedCompensation
41825000
alny Non Cash Gain On Litigation Settlement
NonCashGainOnLitigationSettlement
10000000
us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
2090000
us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
2326000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
21000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
2044000
alny Change In Fair Value Of Liability Obligation
ChangeInFairValueOfLiabilityObligation
9422000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
786000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
772477000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-72193000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
21725000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
47735000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
629384000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11934000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-186750000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-31041000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-18700000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-4480000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15040000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4863000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
21261000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
26369000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-9735000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1427000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
7261000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
399173000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2887000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
100185000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-258351000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
65293000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
43965000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
14825000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
834563000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
642787000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
713106000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
381900000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
400000000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
84000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
632000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
803541000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
47103000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
716973000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-283441000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
422631000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
646832000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1139604000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
363391000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
25893000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
23288000
us-gaap Nature Of Operations
NatureOfOperations
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1. NATURE OF BUSINESS </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We commenced operations on June 14, 2002 as a biopharmaceutical company seeking to develop and commercialize novel therapeutics based on RNA interference, or RNAi. We are committed to the advancement of our company strategy of building a multi-product, commercial biopharmaceutical company with a sustainable pipeline of RNAi therapeutics to address the needs of patients who have limited or inadequate treatment options. Since inception, we have focused on discovering, developing and commercializing RNAi therapeutics by establishing and maintaining a strong intellectual property position in the RNAi field, establishing strategic alliances with leading pharmaceutical and life sciences companies, generating revenues through licensing agreements, and ultimately developing and commercializing RNAi therapeutics globally, either independently or with our strategic partners. We have devoted substantially all of our efforts to business planning, research, development, manufacturing and early commercial efforts, acquiring, filing and expanding intellectual property rights, recruiting management and technical staff, and raising capital. In August 2018, we received approval for ONPATTRO<sup style="font-size:85%; vertical-align:top">®</sup> (patisiran), our first product, from the United States Food and Drug Administration and began commercializing and generating product revenues in the U.S. In August 2018, we also received approval of ONPATTRO from the European Commission and in October 2018, began commercializing and generating product revenues outside of the U.S. <span style="Background-color:#FFFFFF;color:#000000;">In June 2019, we received regulatory approval of ONPATTRO in Japan and Canada</span>. Regulatory filings in additional markets in Europe and elsewhere are pending or planned for the remainder of 2019 and beyond. </p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Reclassification</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior period amounts in the condensed consolidated financial statements have been reclassified to conform to the current period presentation. </p>
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
290000000.0
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
230000000.0
CY2019Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
8446000
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
8709000
CY2019Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
31696000
CY2018Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
15262000
CY2019Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
445000
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
97000
CY2019Q2 us-gaap Inventory Net
InventoryNet
40587000
CY2019Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
13691000
CY2018Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
5625000
CY2019Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
403033000
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3954000
CY2019Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1091000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2019000
CY2018Q4 us-gaap Inventory Net
InventoryNet
24068000
alny Impairment Of Marketable Debt Securities
ImpairmentOfMarketableDebtSecurities
0
alny Impairment Of Marketable Debt Securities
ImpairmentOfMarketableDebtSecurities
0
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
419000
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
18000
CY2019Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1588925000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2019Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1589326000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
35585000
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
884505000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
28686000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
422000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
884084000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
36357000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
36469000
CY2019Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
798784000
CY2018Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
221281000
CY2019Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
790542000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
662803000
CY2019Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1589326000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
884084000
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
9291000
us-gaap Operating Lease Cost
OperatingLeaseCost
18581000
CY2019Q2 us-gaap Variable Lease Cost
VariableLeaseCost
4486000
us-gaap Variable Lease Cost
VariableLeaseCost
9533000
CY2019Q2 us-gaap Lease Cost
LeaseCost
13777000
us-gaap Lease Cost
LeaseCost
28114000
us-gaap Operating Lease Payments
OperatingLeasePayments
16000000.0
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P13Y7M6D
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.082
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
16378000
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
277211000
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
237895000
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
306558000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
29347000
CY2019Q2 alny Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
34676000
CY2019Q2 alny Lessee Operating Lease Liability Payments Due Year Seven And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearSevenAndThereafter
356302000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
544453000
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
306558000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
32228000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
34826000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
34410000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
34826000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
35270000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
390455000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
562015000
CY2019Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5000000
CY2019Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
77.50
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
381900000
CY2019Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
5600000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30603000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22241000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
62635000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41825000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14467000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12944000
CY2019Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
332000
CY2019Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2983000
CY2018Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1934000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1139604000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
363391000
CY2018Q2 alny Litigation Settlement Common Stock Issuable From Other Party
LitigationSettlementCommonStockIssuableFromOtherParty
983208
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1136289000
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
361457000
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-2962000
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
344000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2618000
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
69000
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
557000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
626000

Files In Submission

Name View Source Status
0001564590-19-029367-index-headers.html Edgar Link pending
0001564590-19-029367-index.html Edgar Link pending
0001564590-19-029367.txt Edgar Link pending
0001564590-19-029367-xbrl.zip Edgar Link pending
alny-10q_20190630.htm Edgar Link pending
alny-10q_20190630_htm.xml Edgar Link completed
alny-20190630.xsd Edgar Link pending
alny-20190630_cal.xml Edgar Link unprocessable
alny-20190630_def.xml Edgar Link unprocessable
alny-20190630_lab.xml Edgar Link unprocessable
alny-20190630_pre.xml Edgar Link unprocessable
alny-ex101_475.htm Edgar Link pending
alny-ex102_474.htm Edgar Link pending
alny-ex103_535.htm Edgar Link pending
alny-ex104_534.htm Edgar Link pending
alny-ex105_536.htm Edgar Link pending
alny-ex106_374.htm Edgar Link pending
alny-ex107_375.htm Edgar Link pending
alny-ex108_376.htm Edgar Link pending
alny-ex311_8.htm Edgar Link pending
alny-ex312_10.htm Edgar Link pending
alny-ex321_7.htm Edgar Link pending
alny-ex322_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ght00befacla000001.jpg Edgar Link pending
gprkafembwaf000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending